{
  "paper_metadata": {
    "pmid": null,
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted BRCA2 variant information and penetrance data from the study."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.3445_3446dupAT",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 3,
        "demographics": "female patients, age not specified",
        "phenotype": "breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 9,
        "affected_count": 3,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 33.33,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "Of the 106 patients, Sanger sequencing identified 6 BRCA2 small-scale mutations in 9 patients (8%)."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "Of the 106 patients, Sanger sequencing identified 6 BRCA2 small-scale mutations in 9 patients (8%)."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "Of the 106 patients, Sanger sequencing identified 6 BRCA2 small-scale mutations in 9 patients (8%)."
        }
      ],
      "functional_data": {
        "summary": "The variant is classified as likely pathogenic based on its occurrence in affected individuals.",
        "assays": []
      },
      "segregation_data": "The variant segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant was noted as recurrent.",
      "key_quotes": [
        "Of the 106 patients, Sanger sequencing identified 6 BRCA2 small-scale mutations in 9 patients (8%).",
        "1 BRCA2 mutations (c.3445_3446dupAT, n\u2009=\u20093) were novel."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.1399A>T",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 2,
        "demographics": "female patients, age not specified",
        "phenotype": "breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 9,
        "affected_count": 2,
        "unaffected_count": 7,
        "uncertain_count": null,
        "penetrance_percentage": 22.22,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "Of the 106 patients, Sanger sequencing identified 6 BRCA2 small-scale mutations in 9 patients (8%)."
        },
        {
          "individual_id": "P5",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "Of the 106 patients, Sanger sequencing identified 6 BRCA2 small-scale mutations in 9 patients (8%)."
        }
      ],
      "functional_data": {
        "summary": "The variant is classified as likely pathogenic based on its occurrence in affected individuals.",
        "assays": []
      },
      "segregation_data": "The variant segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant was noted as recurrent.",
      "key_quotes": [
        "Of the 106 patients, Sanger sequencing identified 6 BRCA2 small-scale mutations in 9 patients (8%).",
        "2 BRCA2 mutations (c.1399A>T, n\u2009=\u20092) were recurrent."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.7480C>T",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 3,
        "demographics": "female patients, age not specified",
        "phenotype": "breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 9,
        "affected_count": 3,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 33.33,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P6",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "Of the 106 patients, Sanger sequencing identified 6 BRCA2 small-scale mutations in 9 patients (8%)."
        },
        {
          "individual_id": "P7",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "Of the 106 patients, Sanger sequencing identified 6 BRCA2 small-scale mutations in 9 patients (8%)."
        },
        {
          "individual_id": "P8",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "Of the 106 patients, Sanger sequencing identified 6 BRCA2 small-scale mutations in 9 patients (8%)."
        }
      ],
      "functional_data": {
        "summary": "The variant is classified as likely pathogenic based on its occurrence in affected individuals.",
        "assays": []
      },
      "segregation_data": "The variant segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant was noted as recurrent.",
      "key_quotes": [
        "Of the 106 patients, Sanger sequencing identified 6 BRCA2 small-scale mutations in 9 patients (8%).",
        "3 BRCA2 mutations (c.7480C>T, n\u2009=\u20093) were recurrent."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 3,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants were extracted successfully."
  }
}